The mutations of several genes in different tumor settings such as NRF2 (nuclear factor erythroid 2-related factor 2), KEAP1 (kelch-like ECH-associated protein 1), and KRAS, have been identified as radiosensitising or radioresistant factors [66, 67]. The gene discussed is KRAS; the disease is neoplasm.